Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
56
JXFGF Quote, Financials, Valuation and Earnings
Last price:
$0.29
Seasonality move
:
-23.31%
Day range:
$0.29 - $0.29
52-week range:
$0.28 - $0.29
Dividend yield:
2.63%
P/E ratio:
50.00x
P/S ratio:
2.14x
P/B ratio:
0.55x
Volume:
--
Avg. volume:
--
1-year change:
3.57%
Market cap:
$796M
Revenue:
$368.5M
EPS (TTM):
-$0.05
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
JXFGF
Jinxin Fertility Group Ltd.
|
-- | -- | -- | -- | -- |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -- | -- | -- |
|
VBIZF
Viva Biotech Holdings
|
-- | -- | -- | -- | -- |
|
WXXWY
WuXi Biologics (Cayman), Inc.
|
-- | -- | -- | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$116.5M | -$0.48 | 10.78% | -4.05% | $38.47 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
JXFGF
Jinxin Fertility Group Ltd.
|
$0.29 | -- | $796M | 50.00x | $0.01 | 2.63% | 2.14x |
|
SVA
Sinovac Biotech Ltd.
|
$6.47 | -- | $464.9M | -- | $55.00 | 0% | 1.50x |
|
VBIZF
Viva Biotech Holdings
|
$0.3434 | -- | $724.5M | 16.20x | $0.00 | 1.01% | 3.33x |
|
WXXWY
WuXi Biologics (Cayman), Inc.
|
$8.96 | -- | $18.6B | 27.92x | $0.00 | 0% | 6.24x |
|
ZLAB
Zai Lab Ltd.
|
$20.41 | $38.47 | $2.3B | -- | $0.00 | 0% | 4.87x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
JXFGF
Jinxin Fertility Group Ltd.
|
16.67% | -0.043 | -- | 0.49x |
|
SVA
Sinovac Biotech Ltd.
|
3.46% | 7.237 | 12.91% | 11.22x |
|
VBIZF
Viva Biotech Holdings
|
24.82% | 1.403 | -- | 1.26x |
|
WXXWY
WuXi Biologics (Cayman), Inc.
|
5.93% | 2.689 | -- | 1.98x |
|
ZLAB
Zai Lab Ltd.
|
23.86% | 0.688 | 11.48% | 2.18x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
JXFGF
Jinxin Fertility Group Ltd.
|
-- | -- | 2.51% | 3.05% | -- | -- |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -1.02% | -1.05% | -- | -- |
|
VBIZF
Viva Biotech Holdings
|
-- | -- | -1.17% | -1.8% | -- | -- |
|
WXXWY
WuXi Biologics (Cayman), Inc.
|
-- | -- | 7.16% | 7.53% | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$65.6M | -$69.7M | -17.96% | -22.45% | -54.4% | -$19.1M |
Jinxin Fertility Group Ltd. vs. Competitors
-
Which has Higher Returns JXFGF or SVA?
Sinovac Biotech Ltd. has a net margin of -- compared to Jinxin Fertility Group Ltd.'s net margin of --. Jinxin Fertility Group Ltd.'s return on equity of 3.05% beat Sinovac Biotech Ltd.'s return on equity of -1.05%.
Company Gross Margin Earnings Per Share Invested Capital JXFGFJinxin Fertility Group Ltd.-- -- $1.7B SVASinovac Biotech Ltd.-- -- $11.8B -
What do Analysts Say About JXFGF or SVA?
Jinxin Fertility Group Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sinovac Biotech Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Jinxin Fertility Group Ltd. has higher upside potential than Sinovac Biotech Ltd., analysts believe Jinxin Fertility Group Ltd. is more attractive than Sinovac Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings JXFGFJinxin Fertility Group Ltd.0 0 0 SVASinovac Biotech Ltd.0 0 0 -
Is JXFGF or SVA More Risky?
Jinxin Fertility Group Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sinovac Biotech Ltd. has a beta of 0.887, suggesting its less volatile than the S&P 500 by 11.313%.
-
Which is a Better Dividend Stock JXFGF or SVA?
Jinxin Fertility Group Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.63%. Sinovac Biotech Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $55.00 per share. Jinxin Fertility Group Ltd. pays -- of its earnings as a dividend. Sinovac Biotech Ltd. pays out -328.35% of its earnings as a dividend.
-
Which has Better Financial Ratios JXFGF or SVA?
Jinxin Fertility Group Ltd. quarterly revenues are --, which are smaller than Sinovac Biotech Ltd. quarterly revenues of --. Jinxin Fertility Group Ltd.'s net income of -- is lower than Sinovac Biotech Ltd.'s net income of --. Notably, Jinxin Fertility Group Ltd.'s price-to-earnings ratio is 50.00x while Sinovac Biotech Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jinxin Fertility Group Ltd. is 2.14x versus 1.50x for Sinovac Biotech Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JXFGFJinxin Fertility Group Ltd.2.14x 50.00x -- -- SVASinovac Biotech Ltd.1.50x -- -- --
-
Which has Higher Returns JXFGF or VBIZF?
Viva Biotech Holdings has a net margin of -- compared to Jinxin Fertility Group Ltd.'s net margin of --. Jinxin Fertility Group Ltd.'s return on equity of 3.05% beat Viva Biotech Holdings's return on equity of -1.8%.
Company Gross Margin Earnings Per Share Invested Capital JXFGFJinxin Fertility Group Ltd.-- -- $1.7B VBIZFViva Biotech Holdings-- -- $694.7M -
What do Analysts Say About JXFGF or VBIZF?
Jinxin Fertility Group Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Viva Biotech Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Jinxin Fertility Group Ltd. has higher upside potential than Viva Biotech Holdings, analysts believe Jinxin Fertility Group Ltd. is more attractive than Viva Biotech Holdings.
Company Buy Ratings Hold Ratings Sell Ratings JXFGFJinxin Fertility Group Ltd.0 0 0 VBIZFViva Biotech Holdings0 0 0 -
Is JXFGF or VBIZF More Risky?
Jinxin Fertility Group Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Viva Biotech Holdings has a beta of 0.650, suggesting its less volatile than the S&P 500 by 34.961%.
-
Which is a Better Dividend Stock JXFGF or VBIZF?
Jinxin Fertility Group Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.63%. Viva Biotech Holdings offers a yield of 1.01% to investors and pays a quarterly dividend of $0.00 per share. Jinxin Fertility Group Ltd. pays -- of its earnings as a dividend. Viva Biotech Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JXFGF or VBIZF?
Jinxin Fertility Group Ltd. quarterly revenues are --, which are smaller than Viva Biotech Holdings quarterly revenues of --. Jinxin Fertility Group Ltd.'s net income of -- is lower than Viva Biotech Holdings's net income of --. Notably, Jinxin Fertility Group Ltd.'s price-to-earnings ratio is 50.00x while Viva Biotech Holdings's PE ratio is 16.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jinxin Fertility Group Ltd. is 2.14x versus 3.33x for Viva Biotech Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JXFGFJinxin Fertility Group Ltd.2.14x 50.00x -- -- VBIZFViva Biotech Holdings3.33x 16.20x -- --
-
Which has Higher Returns JXFGF or WXXWY?
WuXi Biologics (Cayman), Inc. has a net margin of -- compared to Jinxin Fertility Group Ltd.'s net margin of --. Jinxin Fertility Group Ltd.'s return on equity of 3.05% beat WuXi Biologics (Cayman), Inc.'s return on equity of 7.53%.
Company Gross Margin Earnings Per Share Invested Capital JXFGFJinxin Fertility Group Ltd.-- -- $1.7B WXXWYWuXi Biologics (Cayman), Inc.-- -- $6.6B -
What do Analysts Say About JXFGF or WXXWY?
Jinxin Fertility Group Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand WuXi Biologics (Cayman), Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Jinxin Fertility Group Ltd. has higher upside potential than WuXi Biologics (Cayman), Inc., analysts believe Jinxin Fertility Group Ltd. is more attractive than WuXi Biologics (Cayman), Inc..
Company Buy Ratings Hold Ratings Sell Ratings JXFGFJinxin Fertility Group Ltd.0 0 0 WXXWYWuXi Biologics (Cayman), Inc.0 0 0 -
Is JXFGF or WXXWY More Risky?
Jinxin Fertility Group Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison WuXi Biologics (Cayman), Inc. has a beta of 0.020, suggesting its less volatile than the S&P 500 by 98.002%.
-
Which is a Better Dividend Stock JXFGF or WXXWY?
Jinxin Fertility Group Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.63%. WuXi Biologics (Cayman), Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jinxin Fertility Group Ltd. pays -- of its earnings as a dividend. WuXi Biologics (Cayman), Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JXFGF or WXXWY?
Jinxin Fertility Group Ltd. quarterly revenues are --, which are smaller than WuXi Biologics (Cayman), Inc. quarterly revenues of --. Jinxin Fertility Group Ltd.'s net income of -- is lower than WuXi Biologics (Cayman), Inc.'s net income of --. Notably, Jinxin Fertility Group Ltd.'s price-to-earnings ratio is 50.00x while WuXi Biologics (Cayman), Inc.'s PE ratio is 27.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jinxin Fertility Group Ltd. is 2.14x versus 6.24x for WuXi Biologics (Cayman), Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JXFGFJinxin Fertility Group Ltd.2.14x 50.00x -- -- WXXWYWuXi Biologics (Cayman), Inc.6.24x 27.92x -- --
-
Which has Higher Returns JXFGF or ZLAB?
Zai Lab Ltd. has a net margin of -- compared to Jinxin Fertility Group Ltd.'s net margin of -39.51%. Jinxin Fertility Group Ltd.'s return on equity of 3.05% beat Zai Lab Ltd.'s return on equity of -22.45%.
Company Gross Margin Earnings Per Share Invested Capital JXFGFJinxin Fertility Group Ltd.-- -- $1.7B ZLABZai Lab Ltd.51.15% -$0.46 $939.8M -
What do Analysts Say About JXFGF or ZLAB?
Jinxin Fertility Group Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Zai Lab Ltd. has an analysts' consensus of $38.47 which suggests that it could grow by 88.47%. Given that Zai Lab Ltd. has higher upside potential than Jinxin Fertility Group Ltd., analysts believe Zai Lab Ltd. is more attractive than Jinxin Fertility Group Ltd..
Company Buy Ratings Hold Ratings Sell Ratings JXFGFJinxin Fertility Group Ltd.0 0 0 ZLABZai Lab Ltd.8 1 0 -
Is JXFGF or ZLAB More Risky?
Jinxin Fertility Group Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Zai Lab Ltd. has a beta of 0.859, suggesting its less volatile than the S&P 500 by 14.084%.
-
Which is a Better Dividend Stock JXFGF or ZLAB?
Jinxin Fertility Group Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.63%. Zai Lab Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jinxin Fertility Group Ltd. pays -- of its earnings as a dividend. Zai Lab Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JXFGF or ZLAB?
Jinxin Fertility Group Ltd. quarterly revenues are --, which are smaller than Zai Lab Ltd. quarterly revenues of $128.2M. Jinxin Fertility Group Ltd.'s net income of -- is lower than Zai Lab Ltd.'s net income of -$50.6M. Notably, Jinxin Fertility Group Ltd.'s price-to-earnings ratio is 50.00x while Zai Lab Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jinxin Fertility Group Ltd. is 2.14x versus 4.87x for Zai Lab Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JXFGFJinxin Fertility Group Ltd.2.14x 50.00x -- -- ZLABZai Lab Ltd.4.87x -- $128.2M -$50.6M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
